[Drug-induced hyperuricemia].
Hamada
Toshihiro
T
Department of Multidisciplinary Internal Medicine, Division of Molecular Medicine and Therapeutics, Tottori University, Faculty of Medicine.
Hisatome
Ichiro
I
Shigemasa
Chiaki
C
D000995:Antitubercular Agents / Q000009:adverse effects*; D004232:Diuretics; D006073:Gout / Q000139:chemically induced / Q000628:therapy; D006801:Humans; D033461:Hyperuricemia / Q000139:chemically induced* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007980:Levodopa / Q000009:adverse effects; D011379:Prognosis; D020156:Salicylic Acid / Q000009:adverse effects; D013806:Theophylline / Q000009:adverse effects
D000995:Antitubercular Agents; D004232:Diuretics; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D007980:Levodopa; D013806:Theophylline; D020156:Salicylic Acid